Use of Cannabidiol-Dominant Extract as Co-Adjuvant Therapy for Type 2 Diabetes Mellitus Treatment in Feline: Case Report
José Ignacio Massabo, Gabriela Puiatti, Paola Ferrero
- ISSN / E-ISSN
- — / —
- DOI
- 10.1159/000541034 ↗
- Volume · Issue · Pages
- 7 · 1 · 206-212
- Publisher
- S. Karger AG
- Article URL
- https://doi.org/10.1159/000541034 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
14 Sep 2024
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 14 Sep 2024 | OpenAlex |
Keywords (as given): cannabidiol; type 2 diabetes; feline diabetes mellitus; cats; insulin dose reduction; glycemic control; tetrahydrocannabinol; polyuria and polydipsia; sleep disorders
HEC Status at Publication Not the journal's current status
HEC Status at PublicationConclusive
HEC status at publication
Recognized
Y
Based on the recorded HEC dataset applicable to the article's publication date. Listed as Y in the HEC list for 2023–24.
- Journal
- Medical Cannabis and Cannabinoids
- Publication date used
- 14 Sep 2024 (OpenAlex publication date)
- Applicable HEC period
- 2023–24 (version 1) · 01 Jul 2023 – 30 Sep 2024
- Category
- Y
- Recognition status
- Recognized (OK_RECORD_FOUND)
- Source
- HJRS 2023-24 page 1702, row 12054
- Verification status
- Verified against source · last verified 23 Sep 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.